Your browser doesn't support javascript.
loading
Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).
Brenkman, H J F; Gertsen, E C; Vegt, E; van Hillegersberg, R; van Berge Henegouwen, M I; Gisbertz, S S; Luyer, M D P; Nieuwenhuijzen, G A P; van Lanschot, J J B; Lagarde, S M; de Steur, W O; Hartgrink, H H; Stoot, J H M B; Hulsewe, K W E; Spillenaar Bilgen, E J; van Det, M J; Kouwenhoven, E A; van der Peet, D L; Daams, F; van Sandick, J W; van Grieken, N C T; Heisterkamp, J; van Etten, B; Haveman, J W; Pierie, J P; Jonker, F; Thijssen, A Y; Belt, E J T; van Duijvendijk, P; Wassenaar, E; van Laarhoven, H W M; Wessels, F J; Haj Mohammad, N; van Stel, H F; Frederix, G W J; Siersema, P D; Ruurda, J P.
Afiliación
  • Brenkman HJF; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Gertsen EC; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Vegt E; The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • van Berge Henegouwen MI; Academic Medical Center, Amsterdam, The Netherlands.
  • Gisbertz SS; Academic Medical Center, Amsterdam, The Netherlands.
  • Luyer MDP; Catharina Hospital, Eindhoven, The Netherlands.
  • Nieuwenhuijzen GAP; Catharina Hospital, Eindhoven, The Netherlands.
  • van Lanschot JJB; Erasmus Medical Center, Rotterdam, The Netherlands.
  • Lagarde SM; Erasmus Medical Center, Rotterdam, The Netherlands.
  • de Steur WO; Leiden University Medical Center, Leiden, The Netherlands.
  • Hartgrink HH; Leiden University Medical Center, Leiden, The Netherlands.
  • Stoot JHMB; Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
  • Hulsewe KWE; Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
  • Spillenaar Bilgen EJ; Rijnstate Hospital, Arnhem, The Netherlands.
  • van Det MJ; ZGT Hospitals, Almelo, The Netherlands.
  • Kouwenhoven EA; ZGT Hospitals, Almelo, The Netherlands.
  • van der Peet DL; VU University Medical Center, Amsterdam, The Netherlands.
  • Daams F; VU University Medical Center, Amsterdam, The Netherlands.
  • van Sandick JW; The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • van Grieken NCT; VU University Medical Center, Amsterdam, The Netherlands.
  • Heisterkamp J; Elisabeth Twee-Steden Hospital, Tilburg, The Netherlands.
  • van Etten B; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Haveman JW; University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Pierie JP; Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Jonker F; Medical Center Leeuwarden, Leeuwarden, The Netherlands.
  • Thijssen AY; Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Belt EJT; Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • van Duijvendijk P; Gelre Ziekenhuis, Apeldoorn, The Netherlands.
  • Wassenaar E; Gelre Ziekenhuis, Apeldoorn, The Netherlands.
  • van Laarhoven HWM; Academic Medical Center, Amsterdam, The Netherlands.
  • Wessels FJ; Propsective Observational Cohort study of Oesophageal-gastric cancer Patients (POCOP) of the Dutch Upper GI Cancer Group (DUCG), Amsterdam, The Netherlands.
  • Haj Mohammad N; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • van Stel HF; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Frederix GWJ; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Siersema PD; Department of Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
  • Ruurda JP; Radboud University Medical Center, Nijmegen, The Netherlands.
BMC Cancer ; 18(1): 450, 2018 04 20.
Article en En | MEDLINE | ID: mdl-29678145
ABSTRACT

BACKGROUND:

Initial staging of gastric cancer consists of computed tomography (CT) and gastroscopy. In locally advanced (cT3-4) gastric cancer, fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT or PET) and staging laparoscopy (SL) may have a role in staging, but evidence is scarce. The aim of this study is to evaluate the impact and cost-effectiveness of PET and SL in addition to initial staging in patients with locally advanced gastric cancer.

METHODS:

This prospective observational cohort study will include all patients with a surgically resectable, advanced gastric adenocarcinoma (cT3-4b, N0-3, M0), that are scheduled for treatment with curative intent after initial staging with gastroscopy and CT. The modalities to be investigated in this study is the addition of PET and SL. The primary outcome of this study is the proportion of patients in whom the PET or SL lead to a change in treatment strategy. Secondary outcome parameters are diagnostic performance, morbidity and mortality, quality of life, and cost-effectiveness of these additional diagnostic modalities. The study recently started in August 2017 with a duration of 36 months. At least 239 patients need to be included in this study to demonstrate that the diagnostic modalities are break-even. Based on the annual number of gastrectomies in the participating centers, it is estimated that approximately 543 patients are included in this study.

DISCUSSION:

In this study, it is hypothesized that performing PET and SL for locally advanced gastric adenocarcinomas results in a change of treatment strategy in 27% of patients and an annual cost-reduction in the Netherlands of €916.438 in this patient group by reducing futile treatment. The results of this study may be applicable to all countries with comparable treatment algorithms and health care systems. TRIAL REGISTRATION NCT03208621 . This trial was registered prospectively on June 30, 2017.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Laparoscopía / Tomografía de Emisión de Positrones / Estadificación de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Laparoscopía / Tomografía de Emisión de Positrones / Estadificación de Neoplasias Tipo de estudio: Clinical_trials / Observational_studies Aspecto: Patient_preference Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos